About this event
In this informative 60-minute masterclass for LSAA members, Oliver Darlington and Andrew Mumford from Initiate will discuss how to meet NICE’s needs in this area of growing importance for payers and HTA bodies.
The session will focus on the NICE real-world evidence framework and its practical meaning to market access professionals.
Andrew is a highly experienced Global Market Access expert, leading pragmatic, solution-focused consultancy services at Initiate, a best-in-class consultancy with exceptional experience in the rare disease sector.
Oliver is the Head of Health Economics at Initiate, a best-in-class consultancy with multi-country and multi-therapy area experience. Oliver has led diverse teams of technical and commercial experts in both the private and public sector to successfully obtain reimbursement and market access for pharmaceutical products across a wide range of disease areas.
Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.
LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.
Share this event